Litcius/Paper detail

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

David Liebowitz, Keith Gottlieb, Nikita Kolhatkar, Shaily Garg, Jason Asher, Jonathan Nazareno, Kenneth H. Kim, David R. McIlwain, Sean N. Tucker

2020The Lancet Infectious Diseases112 citationsDOI

Topics & Concepts

MedicineImmunogenicityInfluenza vaccinePlaceboLive attenuated influenza vaccineClinical trialRandomized controlled trialIntramuscular injectionVaccinationImmunologyVirologyInternal medicineAntibodyAlternative medicinePathologyInfluenza Virus Research StudiesImmunotherapy and Immune ResponsesImmune responses and vaccinations
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study | Litcius